emtricitabine, rilpivirine, tenofovir disoproxil fumarate
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for emtricitabine, rilpivirine, tenofovir disoproxil fumarate, covering 2013-04-19 to 2025-05-20. Get the full timeline:
Most recent: FDA Approved: EMTRICITABINE, RILPIVIRINE, TENOFOVIR DISOPROXIL FUMARATE — Original Application (Mylan Pharmaceuticals Inc.)